An Overview of the HYBRID Study in Elderly Patients With Bladder Cancer

Robert Huddart, professor, The Institute of Cancer Research, discusses the HYBRID trial which assessed hypofractionated bladder radiotherapy with or without image guided adaptive planning in elderly patients with bladder cancer.